Is a complete RNXT research report available?

No complete published report is available for RenovoRx, Inc. (RNXT) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

RenovoRx, Inc. (RNXT)

NASDAQ: RNXT · USD

$0.87

+0.01 (+1.3%)· Recorded snapshot

Coverage state: Market snapshot only — no published research

Market snapshot recorded 2026-07-25 02:00 UTC. No published research is attached to this ticker. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.

On-demand research

Generate the first RNXT analysis

Start the full research workflow when this ticker is ready in our data system.

Market cap	39M
Revenue (ttm)	1.5M
Net income (ttm)	-12.3M
EPS (ttm)	-$0.33
Shares out	45.1M
Volume	148,218
Beta	0.99
Price target	$7.03	+712.4%

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 1.5M
Net income (ttm): -12.3M
EPS (ttm): -$0.33
Market cap: 39M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
ALNY	Alnylam Pharmaceuticals, Inc.	27.4B	36.9x	5.7x	96.6%	+47.5%	-37.8%	Strong Buy
ARGX	argenx SE	53.8B	31.3x	10.1x	50.6%	+58.8%	+45.7%	Strong Buy
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Hold

All RNXT indicators

Market & fundamental data

Available fields

201

Groups with data

Currency

USD

Showing 201 of 201 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001574094
Company name	RenovoRx, Inc.
Country	United States
Country code	US
Cusip	75989R107
Employees	17
Employees Change	7%
Employees Change Percent	70
Enterprise value	$26.3M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
IPO Date	2021-08-26
Isin	US75989R1077
Last refreshed	2026-07-25
Market cap	$39M
Market cap category	Nano-Cap
Price	$0.87
Price currency	USD
Rev Per Employee	87,588.24x
Sector	Healthcare
Sector PE	44.87
Sector PE Fwd	23.76
Sic	2834
Symbol	RNXT
Website	https://renovorx.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-31.89%
EV Sales Forward	5.37x
EV/Sales	17.66x
FCF yield	-29.37%
P/B ratio	3.42x
P/S ratio	25.84x
PS Forward	7.86x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-864.27%
EBITDA Margin	-864.14%
Gross margin	78.71%
Gross Profit	$1.2M
Gross Profit Growth	702.74%
Gross Profit Growth Q	365.05%
Net Income	$-12.3M
Net Income Growth Years	0%
Pretax Margin	-823.98%
Profit Per Employee	$-721,706
ROA	-51.58
Roa5y	-98.12
ROCE	-106.8
ROE	-100.5
Roe5y	-450.7
ROIC	-62.12

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-31.88%
Cagr3y	-25.22%
EPS Growth Years	6
Revenue Growth	520.42x
Revenue Growth Q	185.79x
Revenue Growth Quarters	2x
Revenue Growth Years	1x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.1
Assets	$14M
Cash	$12.4M
Current Assets	$13.7M
Current Liabilities	$1.9M
Debt	$186,000
Debt Equity	$0.02
Equity	$11.3M
Liabilities	$2.7M
Long Term Assets	$244,000
Long Term Liabilities	$779,000
Net Cash	$12.2M
Net Cash By Market Cap	$31.65
Net Cash Growth	-14.85%
Net Debt Equity	$-1.08
Tangible Book Value	$11.3M
Tangible Book Value Per Share	$0.25
WACC	9.64

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	7.15
Net Working Capital	$-454,000
Quick ratio	6.58
Working Capital	$11.8M
Working Capital Turnover	$0.12

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-40.21%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-31.87%
200-day SMA	0.95
3Y total return	-58.2%
50-day SMA	0.89
50-day SMA vs 200-day SMA	50under200
All Time High	16.74
All Time High Change	-94.83%
All Time High Date	2021-08-30
All Time Low	0.53
All Time Low Change	63.08%
All Time Low Date	2023-12-06
ATR	0.05
Beta	0.99
Beta1y	0.84
Beta2y	0.73
Ch YTD	3
High	0.88
High52	1.45
High52 Date	2025-09-19
High52ch	-40.32%
Low	0.84
Low52	0.7
Low52 Date	2025-11-14
Low52ch	23.51%
Ma50ch	-3.23%
Premarket Change Percent	4.49
Premarket Price	$0.89
Premarket Volume	258
Price vs 200-day SMA	-8.64%
RSI	44.73
RSI Monthly	40.28
RSI Weekly	46.08
Sharpe ratio	-0.13x
Sortino ratio	-0.11
Total Return	-40.21%
Tr YTD	3
Tr1m	-4.99%
Tr3m	-3.86%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	4
Analyst Count Top	2
Analyst Price Target Top	$5.5
Analyst Ratings	Strong Buy
Analyst Ratings Top	Buy
Earnings EPS Estimate	$-0.08
Earnings Revenue Estimate	709,000x
Earnings Revenue Estimate Growth	68.01x
Operating Income	$-12.4M
Operating margin	-830.7
Price target	$7.03
Price Target Change	$712
Price Target Change Top	$536

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	39,870,322%
Float Percent	88.41%
Shares Insiders	3.38%
Shares Institutions	10.77%
Shares Out	45,099,133
Shares Qo Q	3.75%
Shares Yo Y	40.21%
Short Float	0.87%
Short Ratio	1.24
Short Shares	0.77

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-12.6M
Average Volume	181,525.5x
Bv Per Share	0.25
Ch1m	-4.99
Ch1y	-31.87
Ch3m	-3.86
Ch3y	-58.2
Ch6m	-13.11
Change	1.26%
Change From Open	0.23
Close	0.85
Days Gap	1.03
Depreciation Amortization	2,000
Dollar Volume	128,253
Earnings Date	2026-08-13
Earnings Time	amc
EBIT	$-12.9M
EBITDA	$-12.9M
EPS	$-0.33
F Score	3
FCF	$-11.3M
FCF EV Yield	-42.97x
FCF Per Share	$-0.25
Financing CF	9,081,000
Fiscal Year End	December
Founded	2,012
Ipr	-90.52
Iprfo	-89.66
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-05-14
Last Report Date	2026-03-31
Last Split Type	Never
Last10k Filing Date	2026-03-30
Ma150	0.93
Ma150ch	-6.89%
Ma20	0.91
Ma20ch	-4.44%
Net CF	-2,220,000
Next Earnings Date	2026-08-13
Open	0.86
Optionable	No
Position In Range	70.59
Post Close	0.87
Postmarket Change Percent	0.54
Postmarket Price	$0.87
Ppne	244,000
Pre Close	0.85
Price Date	2026-07-24
Ptbv Ratio	3.42
Relative Volume	0.82x
Revenue	1,489,000x
SBC By Revenue	87.04x
Share Based Comp	1,296,000
Tr6m	-13.11%
Us State	California
Volume	148,218
Z Score	0.5

RenovoRx, Inc. (RNXT)

Coverage state: Market snapshot only — no published research

Generate the first RNXT analysis

Price

Financial snapshot

Fair-value bridge

Analyst consensus

Latest news · RNXT

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All RNXT indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on RNXT

Frequently asked questions